|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Watson Pharmaceuticals, Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Watson Pharmaceuticals (Watson) is engaged in the development and manufacture of specialty and non-patented pharmaceutical products. The company markets a broad range of generic products for the nephrology, urology, pain management, and therapeutic dermatology markets.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Inspire Pharmaceuticals
Company Financials: DUSA Pharmaceuticals, Inc.
Company Financials: ISTA Pharmaceuticals, Inc.
Company Financials: Gedeon Richter Plc
Company Financials: Alexza Pharmaceuticals
Company Financials: Optimer Pharmaceuticals, Inc.
Company Financials: Sanofi-Aventis SA
Company Financials: Regeneron Pharmaceuticals, Inc.
Company Financials: POZEN, Inc.
Company Financials: DURECT Corporation
|
|
|
|
